Form 8-K · Current report
GE HealthCare 8-K, filed Aug 18, 2026
- Filed
- CIK
- 0001932393
- Accession no.
- 0001932393-26-000050
Summary
GE HealthCare Technologies Inc. appointed William K. Grogan, most recently executive vice president and chief financial officer of Xylem Inc., as its chief financial officer effective September 14, 2026, succeeding Jay Saccaro, who stepped down for a role outside the medical technology industry. Interim CFO George Newcomb will continue as controller and chief accounting officer.
Key points
- Grogan's offer letter provides an annual base salary of $900,000, a target annual bonus of 100% of base salary, and an annual long-term incentive award with a target grant value of $3,300,000.
- He will receive a $550,000 cash sign-on payment for a forfeited 2026 bonus, plus a $4,000,000 one-time sign-on equity award in restricted stock units vesting 50% on each of the first two anniversaries.
- Grogan was CFO of Xylem Inc. from October 2023 and CFO of IDEX Corporation from January 2017 to September 2023; earlier he held finance roles at Walgreens, Crane Co., and Sears Holdings.
- CEO Peter Arduini said Grogan combines financial leadership with an operator's mindset, and Grogan said the company's innovation and patient focus drew him to the role.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (“GE HealthCare”) appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026. George A. Newcomb, who currently serves as GE HealthCare’s interim Chief Financial Officer, will cease serving in that interim role on September 14, 2026, and will continue serving as GE HealthCare’s Controller and Chief Accounting Officer. Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.